Investigation and treatment of premature ovarian insufficiency: A multi-disciplinary review of practice
Post Reproductive Health · 2018-12 · 24 (4) · 155-162
DOI: 10.1177/2053369118811233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Post Reproductive Health, online erschienen am 04.11.2018. Verfasst von A Richardson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Leeds Teaching Hospitals NHS Trust, Leeds, UK. Hauptthemen laut MEDLINE: Guideline Adherence, Patient Care Management, Primary Ovarian Insufficiency, Psychosocial Support Systems. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Objectives
To assess compliance with the European Society for Human Reproduction and Embryology (ESHRE) guidelines on the investigation and management of women with premature ovarian insufficiency at the Leeds Teaching Hospitals NHS Trust (LTHT) and to determine whether this varies depending on the clinical setting in which the women present. Study design A retrospective review of all females diagnosed with premature ovarian insufficiency between 1 July 2016 and 30 June 2017, presenting to one of the following clinics: reproductive medicine, specialist menopause, general gynaecology, oncology long-term follow-up, general endocrinology or paediatric endocrinology. Main outcome measures Proportion of patients who had the necessary investigations performed and relevant treatment options discussed.
Results
103 women were included in the study. Overall, 40.6% had a karyotype. Screening for the Fragile-X pre-mutation, thyroid peroxidase and 21-hydroxylase antibodies occurred in 7.4%, 11.1% and 13.6% of women, respectively. Only 35.9% had their bone mineral density measured. There was significant variation in the performance of a karyotype (p < 0.001) and thyroid peroxidase antibodies (p < 0.01) between the different clinical settings. Overall, lifestyle advice was offered to 30.1%. Estrogen replacement, contraception, fertility options and bone protection were discussed with 76.0%, 38.4%, 59.0% and 75.0%, respectively. Psychological support was offered to 25.2%. There was significant variation for all apart from contraception.
Conclusion
The investigation and treatment of women with premature ovarian insufficiency at the LTHT is not consistent with the ESHRE guidelines and requires improvement. Furthermore, there is significant variation in management depending on the department to which the patient initially presents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
- Department of Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Zitieren
APA
Richardson, A., Haridass, S. A., Ward, E., Ayres, J., & Baskind, N. E. (2018). Investigation and treatment of premature ovarian insufficiency: A multi-disciplinary review of practice. Post Reproductive Health, 24(4), 155-162. https://doi.org/10.1177/2053369118811233
Vancouver
Richardson A, Haridass SA, Ward E, Ayres J, Baskind NE. Investigation and treatment of premature ovarian insufficiency: A multi-disciplinary review of practice. Post Reproductive Health. 2018;24(4):155-162. doi:10.1177/2053369118811233
BibTeX
@article{Richardson2018,
author = {Richardson, A and Haridass, S A and Ward, E and Ayres, J and Baskind, N E},
title = {Investigation and treatment of premature ovarian insufficiency: A multi-disciplinary review of practice},
journal = {Post Reproductive Health},
year = {2018},
volume = {24},
number = {4},
pages = {155--162},
doi = {10.1177/2053369118811233}
}
EUVIMED